Colitis ulcerosa: vizsgálatok itt: Kanada

In Kanada 45 Also abroad 381

45 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Where
Toronto
Életkor
2 év to 17 év
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07158242 · EU 2025-522518-22-01
3. fázisTaking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
London, Montreal, Ottawa, Vancouver
Életkor
18 év to 70 év
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
2. fázisTaking people
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Where
Hamilton, London, Mississauga, Trois-Rivières
Életkor
18 év to 80 év
People
252 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07186101
2. fázisTaking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Greater Sudbury, Halifax, London
Életkor
18 év to 80 év
People
1431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
2. fázisTaking people
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Where
Greenfield Park, Lethbridge, London, Vaughan
Életkor
18 év to 80 év
People
60 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Barrie, Edmonton, Hamilton, Kentville, London, Montreal, Toronto, Vancouver
Életkor
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
1/2. fázisTaking people
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
London, Montreal, Scarborough, Vancouver
Életkor
18 év to 75 év
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990
2. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
London, Montreal
Életkor
18 év and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00
2. fázisTaking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Chicoutimi, Greater Sudbury, London, Montreal, Toronto
Életkor
18 év to 75 év
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
3. fázisTaking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Calgary, Edmonton, London
Életkor
2 év to 17 év
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
2. fázisTaking people
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Where
Québec
Életkor
18 év to 75 év
People
2000 worldwide
Run by
AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00
2. fázisTaking people
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Where
Edmonton, Québec, Winnipeg
Életkor
2 év to 11 év
People
24 worldwide
Run by
Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Hamilton, Oakville, Toronto
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
2. fázisTaking people
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Where
Lethbridge, Montreal, Toronto
Életkor
18 év to 75 év
People
100 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07463183 · EU 2025-523479-49-00
2. fázisTaking people
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Calgary, Edmonton, Greater Sudbury, London, Montreal, Scarborough Village
Életkor
18 év to 75 év
People
204 worldwide
Run by
Palisade Bio
See details and how to joinNCT07845487
2/3. fázisTaking people
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Where
Hamilton, Toronto
Életkor
2 év to 17 év
People
120 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05076175
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Edmonton, Hamilton, London, New Westminster, Toronto
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
No phaseTaking people
The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)
Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, St. John's, Toronto, Vancouver, Winnipeg
Életkor
2 év to 17 év
People
2400
Run by
The Hospital for Sick Children
See details and how to joinNCT02308917
No phaseTaking people
Genome Analysis Across Populations in Inflammatory Bowel Disease
Where
Toronto
People
150
Run by
Mount Sinai Hospital, Canada
See details and how to joinNCT06042387
2. fázisTaking people
Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
Where
Hamilton
Életkor
18 év and over
People
14
Run by
McMaster University
See details and how to joinNCT07341282
3. fázisTaking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
London, Toronto
Életkor
2 év to 19 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
1. fázisTaking people
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Where
Toronto
Életkor
18 év and over
People
300 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03816345
No phaseTaking people
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
Where
Hamilton
Életkor
18 év to 70 év
People
15
Run by
McMaster University
See details and how to joinNCT06548399
No phaseTaking people
TIDHI Mental Health in IBD Patients Study
Where
North YORK
Életkor
18 év to 75 év
People
100
Run by
TIDHI Innovation Inc.
See details and how to joinNCT07013578
No phaseNot yet taking people in Kanada
Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development
Where
Vancouver
Életkor
18 év and over
People
95
Run by
University of British Columbia
See details and how to joinNCT07814274